CRSP CRISPR Therapeutics AG

$51.72▼ -1.03% Healthcare Other
After hours $51.80▲ +0.15% Sep 11, 7:47 PM ET
Volume 854.5K Avg Volume (10D) 1.20M
Key Metrics & Fundamentals
Market Cap
$5.00B
P/E Ratio
–
Div Yield
–%
52W Range
44.12 - 78.48
% vs 50 MA
-3.46%
% vs 200 MA
-2.93%
RSI-14
39.3
MACD Histogram
-0.8900
Beta (1Y vs SPY)
1.79
Free Cash Flow
-$86.62M
Gross Rev
$10.00M
Gross Profit
-$30.27M
EBITDA
-$112.99M
COGS
$40.27M
Operating Exp
$87.00M
Operating Income
-$117.27M
EBIT
-$117.27M
Pretax Income
-$90.19M
Net Income
-$91.15M
EPS (Diluted)
-0.94
Price & Volume History
Loading chart…
Recent News
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · Sep 11, 2026 3:29 PM
Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · Sep 11, 2026 2:50 PM
Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September
Motley Fool · Sep 11, 2026 9:35 AM
Rocket Pharmaceuticals (RCKT) Up 6% Since Last Earnings Report: Can It Continue?
Zacks · Sep 9, 2026 3:30 PM
Why CRISPR Therapeutics Stock Rocked the Market Last Month
Motley Fool · Sep 8, 2026 9:45 PM
3 Promising Genomics Stocks in the Spotlight in 2026
Zacks · Sep 8, 2026 4:46 PM
Where Will CRISPR Therapeutics Stock Be in 5 Years?
Motley Fool · Sep 8, 2026 3:20 PM
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire · Sep 8, 2026 12:30 PM
Why Is Ultragenyx (RARE) Up 6.4% Since Last Earnings Report?
Zacks · Sep 3, 2026 3:30 PM
2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026
Motley Fool · Sep 2, 2026 11:05 PM
Financial Overview - Income Statement Quarterly

See CRSP's money flow as a full page

Social Sentiment
Avg +0.40 · 38 posts
DDDiscussionRetention check hit this morning, ready to go full regard.
r/wallstreetbets · Aug 12, 2026
The user describes CRSP as a 'strong conviction case,' indicating a positive outlook.
positive +0.70
NewsDiscussionWhat if the next AI is genetics?
r/StockMarket · Jun 2, 2026
The post highlights CRSP's role in gene-editing therapies, indicating a positive view.
positive +0.60
NewsDiscussionWhat if the next AI is genetics?
r/stocks · Jun 2, 2026
Discusses a potentially disruptive technology and the company's involvement.
positive +0.60
CRSP is heading to $25 before it goes up to $97 (in 4 years)
r/stocks · Apr 19, 2026
Significant net losses, high operating loss, debt issuance, and a long cash burn rate indicate a negative outlook for CRSP.
negative -0.70
DDNewsDiscussionWhy don't more people talk about and invest in indexes built by academics and economists with decades of data behind them ?
r/investing · Mar 5, 2026
Central to the discussion of academically-designed indexes.
positive +0.80
Page 1 of 8 (38 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙